{ "items": [ "\n\n
\n \n 11 April 2016\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nYou are invited to take part in a study to investigate how different vaccines prevent infection with Salmonella Typhi.
\n \n\n\n \n 23 March 2016\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Oxford Vaccine Group is running a study to check whether a new vaccine helps to prevent chickenpox.
\n \n\n\n \n 1 March 2016\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nMeasles is a highly infectious viral disease which can lead to serious complications. In high income regions of the world such as Western Europe, it causes death in at least 1 in 5000 cases, but as many as 1 in 100 will die in the poorest regions of the world.
\n \n\n\n \n 24 February 2016\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nA petition calling for the meningitis B vaccine to be given to all children, at least up to age 11 years, has gained a record number of signatoriesfollowing the high profile case of a two-year-old child who died from the infection and whose parents believed they should have received the vaccine. So what is meningitis B and why is the vaccine for it only given to babies under the age of one?
\n \n\n\n \n 22 February 2016\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Matthew Snape is a guest on Sierra Leone's radio programme Pikin to Pikin Tok.
\n \n\n\n \n 20 January 2016\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nThe NIHR Oxford Biomedical Research Centre (BRC) and the NIHR Oxford Biomedical Research Unit in Musculoskeletal Disease (BRU) have announced the successful applicants for its first Principal Fellow Competition. A total of \u00a3675,000 has been awarded to senior Oxford researchers to support research that will have a direct benefit on NHS care.
\n \n\n\n \n 20 January 2016\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nFacebook co-founder Mark Zuckerberg recently posted a photo on the social networking site of his two-month-old daughter in the doctor\u2019s surgery waiting to be vaccinated. It provoked a storm on social media, with millions of people commenting on the pros and cons of vaccination. So was Zuckerberg right to have his child vaccinated?
\n \n\n\n \n 3 December 2015\n \n
\n\n \n\n \n\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University researchers are making important progress evaluating the impact of an important new programme to save the lives of children in Nepal, which is being discussed in Geneva this week.
\n \n\n\n \n 25 November 2015\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nShrijana Shrestha, Imran Ansari, Bibek Khadka & Sanjeev Bijukchhe talk about their experiences of the earthquakes that took place in Nepal this year. Sarah Kelly has added images to the soundtrack and originally presented it at the Oxford Vaccine Group away day. However, we wanted to share the moving stories here too for all to listen to.
\n \n\n\n \n 24 November 2015\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Sadarangani gave a talk on the body's immune response to novel vaccines at the Winter Science Meeting 2015 at the Academy of Medical Sciences this month. His efforts to make the talk accessible and engage with a lay audience won him the Communications Prize.
\n \n\n\n \n 23 November 2015\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nTake part in our new study looking at flu vaccines
\n \n\n\n \n 10 November 2015\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are looking for healthy adults to take part in the initial trial of a potential new vaccine against a virus considered to be a crucial missing element in the childhood vaccination programme.\r\n\r\n**Please note, this study has recruited a sufficient number of participants**
\n \n\n\n \n 7 September 2015\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nAll you need to know about vaccines and infectious diseases in one handy app!
\n \n\n\n \n 13 August 2015\n \n
\n\n \n\n \n\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from Oxford University's Department of Paediatrics have successfully completed the first human trial of a vaccine for a common virus that is particularly dangerous to infants.
\n \n\n\n \n 10 August 2015\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 16 July 2015\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nA vaccine study involving healthy adults
\n \n\n\n \n 15 July 2015\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
\n \n\n\n \n 15 June 2015\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are now recruiting volunteers for Oxford Vaccine Group's new Ebola study: Evaluating Optimal Vaccine Schedules against Ebola (EVOLVE)
\n \n\n\n \n 16 April 2015\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Oxford Vaccine Group in the Department is currently looking to recruit healthy adults aged between 18 to 60 in a study investigating how the adult immune system responds to a new meningococcal B vaccine.
\n \n\n